/
ImmunityBio, Inc.
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases.
Mentions
2 mentions · latest on 30 Sept 2026
See which tracked investors hold ImmunityBio, Inc. →Ownership and position changes on OwnershipTrace
| Life Extension per Token | - | 30 Sept 2026 | |
| NervGen: Chasing Ozempic for the Nervous System. | - | 15 Jun 2026 |